{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-004428","form_type":"8-K","ticker":"LYRA","cik":"0001327273","company_name":"Lyra Therapeutics, Inc.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.319605+00:00","generated_at":"2026-05-28T04:37:15.763952+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Lyra Therapeutics posts corporate presentation; no new facts extractable from exhibit content provided","bullets":["Company furnished a corporate presentation as Exhibit 99.1 to the SEC on January 10, 2025.","The full content of the presentation is not included in the filing text submitted for analysis.","Investors should view the presentation on Lyra's website for any updates on strategy or pipeline.","No specific financial or operational numbers, guidance changes, or milestones are disclosed in the 8-K body."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-004428","json":"https://secwatch.observer/filing/0001193125-25-004428.json","markdown":"https://secwatch.observer/filing/0001193125-25-004428.md","text":"https://secwatch.observer/filing/0001193125-25-004428.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1327273/000119312525004428/0001193125-25-004428-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1327273/000119312525004428/d905375d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:37:15.763952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}